This webinar provides an in-depth look at the role of Cangrelor in Percutaneous Coronary Intervention (PCI), exploring its clinical benefits and place in modern cardiology practice. Participants will gain insights into the latest evidence surrounding Cangrelor, a potent intravenous P2Y12 inhibitor, and its impact on outcomes during PCI procedures. Designed for healthcare professionals, this webinar will discuss current guidelines and best practices for the use of Cangrelor in the management of patients undergoing PCI, with a focus on optimizing procedural success and minimizing complications.